Better Artificial Intelligence Stock: Palantir vs. Nvidia

The first quarter of 2025 was challenging for Moderna, with shares sliding 31.8% as the S&P 500 and Nasdaq Composite also saw losses. The company's revenues plummeted, leading to a significant decline in sales and lowered guidance for 2025. The resignation of FDA official Peter Marks added to investor concerns, with analysts warning of potential delays in Moderna's vaccine development programs. Full Article

The Motley Fool Scoreboard episode explores Nvidia (NVDA -1.64%) with expert analysts, offering insights into market trends and potential investment opportunities. The video, published on April 8, 2025, uses stock prices from Feb. 28, 2025, to discuss the exciting world of Nvidia, providing valuable information for investors looking to understand the company's performance and prospects in the market.https://www.youtube.com/watch?v=o4H2L7r8vZg Full Article

XRP's token price dropped by 5.4% in the last 24 hours, while Bitcoin fell by 2.6% and Ethereum by 6.1%. The overall market saw a sell-off due to evolving tariff concerns, with XRP down 8% for the year and 43% from its all-time high. The outlook on tariffs and macroeconomic factors will likely drive XRP's valuation, posing risks to its speculative nature if investors become more risk-averse. Full Article

Shares of Rigetti Computing (RGTI -7.56%) plummeted 48.1% in Q1 2025, following a significant drop in January and slower declines in the subsequent months, despite a 925% increase in the last six months. The hype surrounding quantum computing, fueled by the release of the Willow chip by Alphabet's Google Quantum Computing AI team, led to inflated expectations that were later tempered by Nvidia CEO Jensen Huang's cautionary remarks at a tech conference in January, revealing...

Alphabet's shares dropped 22.1% in Q1 2025 due to a disappointing Q4 report with mixed earnings, high AI demand taxing Google Cloud infrastructure, and increased capital expenses. Despite short-term setbacks, Alphabet's long-term outlook remains strong, with a history of outperforming the market in next-gen tech areas like AI and quantum computing. The recent price drop presents a buying opportunity for investors looking to capitalize on Alphabet's growth potential. Full Article

Shares of MongoDB (MDB) plummeted 34% last month following disappointing 2025 guidance and a market sell-off, despite beating revenue and earnings estimates in the fourth quarter. The company's cloud-based product MongoDB Atlas saw strong growth, but concerns over slowing revenue growth and reduced earnings projections led to a stock downgrade by analysts. MongoDB's management attributes the growth slowdown to limited multiyear deal cohorts and margin challenges, causing the stock to trade at a high forward...